Gene · 10857
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclical Iron Homeostasis: The Role of Sex Hormones in Female Iron Regulation. | Front Biosci (Landmark Ed) | 2026 | 42811967 | PubTator, text mining | PubMed |
| Epitranscriptomic stabilization of PGRMC1 by the METTL3-IGF2BP1 axis promotes ovarian cancer progression. | Cell Signal | 2026 | 42777928 | PubTator, text mining | PubMed |
| COMMD3 coordinates mannose-6-phosphate receptor trafficking to sustain lysosomal protease maturation. | Res Sq | 2026 | 42774043 | PubTator, text mining | PubMed |
| Absence of Receptor Mediated Functional Progesterone Withdrawal in the Decidua During Labor-like Inflammatory Conditions. | Am J Reprod Immunol | 2026 | 42748907 | PubTator, text mining | PubMed |
| Identification of TIMP1 as a Key Regulator of Ferroptosis in Ulcerative Colitis Through Bioinformatics and Functional Experiments. | Gastroenterol Res Pract | 2026 | 42592064 | PubTator, text mining | PubMed |
| Arsenic Exposure During Pregnancy: Impacts to Maternal and Offspring Cardiovascular Health. | Med Res Arch | 2026 | 42459294 | PubTator, text mining | PubMed |
| PGRMC1 suppression enhances progesterone responsiveness in stromal cells of ovarian endometrioma. | Reproduction | 2026 | 42406423 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism. | Cell Rep | 2026 | 42287635 | PubTator, text mining | PubMed |
| A proteogenomic RNA processing mechanism drives sex differences in meningioma. | Res Sq | 2026 | 42282014 | PubTator, text mining | PubMed |
| Uncovering Common Anti-Inflammatory Targets of DHEA, 5-AED, Progesterone, and Gestobutanoyl. | Curr Med Chem | 2026 | 42163697 | PubTator, text mining | PubMed |
| The trophoblastic theory of cancer: Progesterone-dependent immune tolerance and modulation by synthetic and natural antagonists. | Biomed Pharmacother | 2026 | 41895062 | PubTator, text mining | PubMed |
| Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial. | Ann Surg Oncol | 2026 | 41880079 | PubTator, text mining | PubMed |
| Materials-Driven Fluorescent Sensor Array of Dye-Derived Carbon Dots for Sensitive Detection of Multiple Proteins and the Cancer Biomarker Progesterone Receptor Membrane Component-1. | Anal Chem | 2026 | 41778706 | PubTator, text mining | PubMed |
| Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening. | Sci Rep | 2026 | 41775739 | PubTator, text mining | PubMed |
| Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. | Mol Biomed | 2026 | 41772328 | PubTator, text mining | PubMed |
| Nuclear and membrane-bound hormone receptors in glioblastoma: Expression, functionality, and therapeutic implications. | Neurooncol Adv | 2026 | 41768124 | PubTator, text mining | PubMed |
| Pathologic response and nodal status guide adjuvant immunotherapy in non-small cell lung cancer after neoadjuvant chemoimmunotherapy: An eastern Asian cohort study. | J Thorac Cardiovasc Surg | 2026 | 41765326 | PubTator, text mining | PubMed |
| Progesterone-driven stabilization of hybrid E/M states in amniotic epithelial cells enhances regeneration and immune modulatory capacities. | iScience | 2026 | 41756729 | PubTator, text mining | PubMed |
| Gene Expression Profiling and Prognostic Significance of Nuclear and Membrane Progesterone Receptors in Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2026 | 41751984 | PubTator, text mining | PubMed |
| Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis. | PLoS Pathog | 2026 | 41739884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10857/papers